SOX11 holds mantle cell lymphoma’s key to home

Slides:



Advertisements
Similar presentations
Egress of CD19 + CD5 + cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients.
Advertisements

Lymphoma dissemination: the other face of lymphocyte homing by Steven T. Pals, David J. J. de Gorter, and Marcel Spaargaren Blood Volume 110(9):
The β2 integrin–kindlin-3 interaction is essential for T-cell homing but dispensable for T-cell activation in vivo by Vicky Louise Morrison, Matthew MacPherson,
The angiogenesis inhibitor vasostatin is regulated by neutrophil elastase–dependent cleavage of calreticulin in AML patients by Sarah Mans, Yara Banz,
Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.
Extracellular matrix protein tenascin-C is required in the bone marrow microenvironment primed for hematopoietic regeneration by Ayako Nakamura-Ishizu,
Beyond hydroxyurea: new and old drugs in the pipeline for sickle cell disease by Marilyn J. Telen Blood Volume 127(7): February 18, 2016 ©2016 by.
EBV-positive diffuse large B-cell lymphoma of the elderly by Chi Young Ok, Thomas G. Papathomas, L. Jeffrey Medeiros, and Ken H. Young Blood Volume 122(3):
Altered B-cell receptor signaling kinetics distinguish human follicular lymphoma B cells from tumor-infiltrating nonmalignant B cells by Jonathan M. Irish,
T-ALL: Home Is where the CXCL12 Is
CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation.
The PI3K Delta Inhibitor TGR-1202 and Proteasome Inhibitor Carfilzomib Are Highly Synergistic In Killing Human B- and T-Cell Lymphoma Cells by Changchun.
Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene by A.
by Dai Chida, Osamu Miura, Akihiko Yoshimura, and Atsushi Miyajima
The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma by Jonathan.
Is hematopoietic stem cell homing deficient in Fanconi anemia?
by Paolo Strati, and Tait D. Shanafelt
“Vitamin hypothesis”: explanation for allergy increase?
by Laurence J. N. Cooper, Kevin M. Shannon, Michael R
by David W. Bahler, John A. Miklos, and Steven H. Swerdlow
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
CD146 (Mel-CAM), an adhesion marker of endothelial cells, is a novel marker of lymphocyte subset activation in normal peripheral blood by Mohamed F. Elshal,
BRAF inhibitor: targeted therapy in hairy cell leukemia
Leukemia initiated by PMLRARα: the PML domain plays a critical role while retinoic acid–mediated transactivation is dispensable by Scott C. Kogan, Suk-hyun.
Skovseth et al. Endostatin dramatically inhibits endothelial cell migration, vascular morphogenesis, and perivascular cell recruitment in vivo. Blood.
Mutagenic potential of temozolomide in bone marrow cells in vivo
Fusion genes in cord blood
Engineering regulatory T cells against factor VIII inhibitors
Lymphoma dissemination: the other face of lymphocyte homing
Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B.
Targeting kinases in CML CLL
Relationship of p53, bcl-2, and Tumor Proliferation to Clinical Drug Resistance in Non-Hodgkin's Lymphomas by Wyndham H. Wilson, Julie Teruya-Feldstein,
Setting the table for macrophages
Detection of Trisomy 12 and Rb-Deletion in CD34+ Cells of Patients With B-Cell Chronic Lymphocytic Leukemia by B. Gahn, C. Schäfer, J. Neef, C. Troff,
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapy by Mark P. Chao, Chad Tang, Russell K. Pachynski,
by Douglas D. Ross, Judith E. Karp, Tar T. Chen, and L. Austin Doyle
ROCK and Rho(ll) in bone marrow
BCL-6 Protein Expression in Human Peripheral T-Cell Neoplasms Is Restricted to CD30+ Anaplastic Large-Cell Lymphomas by Antonino Carbone, Annunziata Gloghini,
Lymphoma spread? Target CD47-SIRPα!
Expression of the Human Immunodeficiency Virus-Tat Gene in Lymphoid Tissues of Transgenic Mice Is Associated With B-Cell Lymphoma by Ramendra K. Kundu,
by George Z. Rassidakis, Mauricio P. Oyarzo, and L. Jeffrey Medeiros
ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase.
Yang et al. SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood. 2008;112(3):805–813. Blood Volume 114(14): October.
HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8–positive plasmablastic lymphoma by Nicolas Dupin, Tim L.
Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray by Wolf-K. Hofmann, Sven de Vos, Kunihiro Tsukasaki, William.
Peter Celec, Yoshikazu Yonemitsu  Pathophysiology 
Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation by Wenbin Xiao, Mariko Yabe, Michael.
Ikaros: Exploiting and targeting the hematopoietic stem cell niche in B-progenitor acute lymphoblastic leukemia  Michelle L. Churchman, Charles G. Mullighan 
Biological network analysis of differentially expressed proteins in both pancreatic cancer and chronic pancreatitis using MetaCore mapping tool. Biological.
Current understanding of stem cell mobilization
by Geling Li, Emily Waite, and Julie Wolfson
by Tadayuki Yago, Nan Zhang, Liang Zhao, Charles S
HoxA9 directly regulates cell cycle control genes.
A case of lenalidomide-dependent myelodysplastic syndrome
Cord blood transplantation recapitulates fetal ontogeny with a distinct molecular signature that supports CD4+ T-cell reconstitution by Prashant Hiwarkar,
Pain. Pain. (A) Skeletal pain experienced by bone marrow (BM) and peripheral blood stem cell (PBSC) donors at baseline, during the pericollection period,
Schematic model of the mechanism of Tak1 protection of HSPC survival.
Receptor tyrosine kinase (RTK) responds to external stimuli including extracellular matrix components and chemokines and subsequently activates phosphoinositide.
Resistance mechanism for ibrutinib in marginal zone lymphoma
Leukemic blasts express a “hypoxia signature
Biology and treatment of Richter syndrome
IL6 mRNA is not detected in metastatic prostate cancer cells.
CR-rate ratios with 95% CIs
Mesenchymal Stem Cell-Derived Vesicles Reverse Hematopoietic Radiation Damage by Sicheng Wen, Laura R Goldberg, Mark S Dooner, John L Reagan, and Peter.
Representative staining of bone marrow aspirates collected from a patient at baseline and after 1 cycle of treatment with 45 mg/m2 selinexor + 20 mg dexamethasone,
Hepatosplenic T-Cell Lymphoma: Clinicopathological Features and Treatment Outcomes: Report From The North American Peripheral T-Cell Lymphoma Consortium.
Constitutive expression of JAK3M511I and HOXA9 leads to development of both AML and T-ALL in vivo. Constitutive expression of JAK3M511I and HOXA9 leads.
CD38 and chronic lymphocytic leukemia: a decade later
The interplay of leukemia cells and the bone marrow microenvironment
A schematic diagram showing the mechanism by which L5 triggers platelet activation and aggregation. A schematic diagram showing the mechanism by which.
Presentation transcript:

SOX11 holds mantle cell lymphoma’s key to home by David Dominguez-Sola Blood Volume 130(4):389-391 July 27, 2017 ©2017 by American Society of Hematology

Balsas et al show how SOX11 expression in MCL (here marked with a brown nuclear staining) activates a gene expression program mediating cell adhesion and homing in lymph nodes and bone marrow. Balsas et al show how SOX11 expression in MCL (here marked with a brown nuclear staining) activates a gene expression program mediating cell adhesion and homing in lymph nodes and bone marrow. This gene program controls the expression of CXCR4 and FAK, which are critical mediators of cell-cell interactions driving the migration and homing of MCL cells into these tissues. SOX11 depletion, or lack of SOX11 expression as it occurs in a subset of indolent, leukemic non-nodal MCLs (blue-only cells), prevents these interactions, causing the redistribution of MCL cells to peripheral blood, away from homing tissue niches. PI3K, phosphatidylinositol 3-kinase. ERK, extracellular signal-regulated kinases. David Dominguez-Sola Blood 2017;130:389-391 ©2017 by American Society of Hematology